MedPath

Ramezole

Brand Name: Ramezole

Generic Name: Omeprazole (As Sodium)

Active
Registration Number

DRP-5041-01

Dosage Form

Lyophilized Powder for Injection

Issuance Date

March 31, 2023

Expiry Date

June 27, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40 mg Lyophilized
Packaging10 mL USP Type I Clear and Colorless glass vial + 10mL 0.9% Sodium Chloride as diluents in USP Type I Clear and Colorless glass ampoule (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Proton Pump Inhibitors
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Omeprazole (As Sodium)Active
Monograph: omeprazole (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform